Crossref
Endocrine Therapy in Low-Grade Serous Ovarian Cancer: From Biological Rationale to Emerging Combination Strategies
Oncology Research · 2026 · 1-10
DOI: 10.32604/or.2026.084204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Fulvio Borella und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Borella, F., Cosma, S., Gallio, N., Dragone, G., Arridu, S., Capella, G., Hotot, M., Battista, E., Cassoni, P., & Castellano, I. (2026). Endocrine Therapy in Low-Grade Serous Ovarian Cancer: From Biological Rationale to Emerging Combination Strategies. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.084204
Vancouver
Borella F, Cosma S, Gallio N, Dragone G, Arridu S, Capella G, et al. Endocrine Therapy in Low-Grade Serous Ovarian Cancer: From Biological Rationale to Emerging Combination Strategies. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.084204
BibTeX
@article{Borella2026,
author = {Borella, Fulvio and Cosma, Stefano and Gallio, Niccolò and Dragone, Giorgia and Arridu, Stefania and Capella, Giulia and Hotot, Mathilde and Battista, Eleonora and Cassoni, Paola and Castellano, Isabella},
title = {Endocrine Therapy in Low-Grade Serous Ovarian Cancer: From Biological Rationale to Emerging Combination Strategies},
journal = {Oncology Research},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/or.2026.084204}
}
EUVIMED